Biofilm Production by Critical Antibiotic-Resistant Pathogens from an Equine Wound.

Ana C Afonso, Mariana Sousa, Ana Rita Pinto, Mário Cotovio, Manuel Simões, Maria José Saavedra
Author Information
  1. Ana C Afonso: LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, Department of Chemical Engineering, University of Porto, 4200-465 Porto, Portugal. ORCID
  2. Mariana Sousa: LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, Department of Chemical Engineering, University of Porto, 4200-465 Porto, Portugal.
  3. Ana Rita Pinto: CITAB-Centre for the Research and Technology of Agro-Environmental and Biological Sciences and Inov4Agro, University of Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal.
  4. Mário Cotovio: Department of Veterinary Sciences-Antimicrobials, Biocides & Biofilms Unit, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal. ORCID
  5. Manuel Simões: LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, Department of Chemical Engineering, University of Porto, 4200-465 Porto, Portugal. ORCID
  6. Maria José Saavedra: CITAB-Centre for the Research and Technology of Agro-Environmental and Biological Sciences and Inov4Agro, University of Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal. ORCID

Abstract

As in human medicine, in veterinary medicine, chronic wounds are often related to polymicrobial infections and the presence of a biofilm, which compromises the effectiveness of therapeutic approaches. In this study, a Lusitano mare presented a 21-day-old chronic wound that was only being treated with an antiseptic. A swab sample was collected, and three isolates of and one of were isolated. did not show resistance to a panel of antibiotics. However, the isolate showed a resistance profile to carbapenems and fluoroquinolones, which may suggest a cross-resistance between antiseptic and antibiotics, given that no antibiotic therapy was applied to the wound or the mare in the previous year. Further experiments were conducted to assess the ability of the isolates to form biofilms, and to ascertain their susceptibility to Gentamicin. The results demonstrated that the isolates produced biofilms. Gentamicin at the minimum inhibitory concentration (MIC) and 10× MIC caused biofilm removal between 59.3% and 85.7%, with the highest removal percentage being obtained for the isolate (at 10× MIC concentration). This study reveals that an Equine wound was colonized by antibiotic resistant bacteria, and that all the wound colonizers could form biofilms, demonstrating the relevance of an adequate diagnosis and treatment when there is a suspicion of a biofilm-infected wound. It also highlights the possibility of resistance transmission between animals, animals and humans, or animals and the environment.

Keywords

References

  1. Microb Drug Resist. 2020 Oct;26(10):1174-1185 [PMID: 32354251]
  2. PLoS One. 2020 Jul 29;15(7):e0236761 [PMID: 32726347]
  3. J Glob Antimicrob Resist. 2016 Dec;7:61-66 [PMID: 27639138]
  4. Vet Microbiol. 2011 May 12;150(1-2):152-9 [PMID: 21273008]
  5. Vet J. 2017 Jul;225:63-68 [PMID: 28720301]
  6. Wound Repair Regen. 2008 Jan-Feb;16(1):37-44 [PMID: 18086294]
  7. Antibiotics (Basel). 2021 Jan 31;10(2): [PMID: 33572528]
  8. J Anim Sci Technol. 2022 Sep;64(5):997-1007 [PMID: 36287738]
  9. Lancet Infect Dis. 2018 Mar;18(3):318-327 [PMID: 29276051]
  10. Front Cell Infect Microbiol. 2022 Jan 05;11:795797 [PMID: 35071046]
  11. Clin Microbiol Rev. 2002 Apr;15(2):167-93 [PMID: 11932229]
  12. Cell Host Microbe. 2019 Jul 10;26(1):15-21 [PMID: 31295420]
  13. Int J Mol Sci. 2019 Jul 12;20(14): [PMID: 31336824]
  14. Front Microbiol. 2020 May 21;11:928 [PMID: 32508772]
  15. Antimicrob Agents Chemother. 2015 Mar;59(3):1707-17 [PMID: 25583711]
  16. Vet World. 2016 Jan;9(1):12-8 [PMID: 27051178]
  17. Can J Microbiol. 2009 Feb;55(2):197-202 [PMID: 19295652]
  18. Adv Wound Care (New Rochelle). 2013 Sep;2(7):389-399 [PMID: 24527355]
  19. Ther Adv Infect Dis. 2016 Feb;3(1):15-21 [PMID: 26862399]
  20. Front Microbiol. 2015 Oct 31;6:1216 [PMID: 26583011]
  21. J Equine Vet Sci. 2019 Jan;72:1-7 [PMID: 30929771]
  22. Pathogens. 2014 Jun 18;3(2):473-98 [PMID: 25437810]
  23. Antimicrob Agents Chemother. 2016 Dec 27;61(1): [PMID: 27799211]
  24. J Microbiol Methods. 2000 Apr;40(2):175-9 [PMID: 10699673]
  25. Foodborne Pathog Dis. 2018 Aug;15(8):467-474 [PMID: 29708778]
  26. Front Microbiol. 2021 Nov 25;12:776909 [PMID: 34899659]
  27. Vet Rec. 2020 Nov 14;187(10):404 [PMID: 32719083]
  28. Nat Rev Microbiol. 2004 Feb;2(2):95-108 [PMID: 15040259]
  29. Vet Dermatol. 1997 Dec;8(4):273-290 [PMID: 34645017]
  30. Clin Microbiol Rev. 2001 Apr;14(2):244-69 [PMID: 11292638]
  31. Vet Dermatol. 2022 Feb;33(1):91-e27 [PMID: 34704298]
  32. Future Microbiol. 2012 Sep;7(9):1061-72 [PMID: 22953707]
  33. Appl Environ Microbiol. 2007 Oct;73(19):6192-200 [PMID: 17675433]
  34. Appl Environ Microbiol. 2010 Oct;76(19):6673-9 [PMID: 20693444]
  35. Biomed J. 2014 Nov-Dec;37(6):411-4 [PMID: 25179712]
  36. Antibiotics (Basel). 2022 Jan 07;11(1): [PMID: 35052946]
  37. Int J Mol Sci. 2021 Jul 31;22(15): [PMID: 34361044]
  38. Biol Proced Online. 2019 Sep 13;21:18 [PMID: 31528123]
  39. Antibiotics (Basel). 2020 Feb 16;9(2): [PMID: 32079072]

Grants

  1. (2020.04773.BD)/FCT grant
  2. UIDB/AGR/04033/2020 (CITAB)/FCT/MCTES (PIDDAC); Germirrad-POCI-01-0247-FEDER-072237, funded by FEDER funds through COMPETE2020
  3. UIDB/CVT/00772/2020 (CECAV)/FCT/MCTES (PIDDAC); Germirrad-POCI-01-0247-FEDER-072237, funded by FEDER funds through COMPETE2020
  4. LA/P/0045/2020 (ALiCE)/FCT/MCTES (PIDDAC); Germirrad-POCI-01-0247-FEDER-072237, funded by FEDER funds through COMPETE2020
  5. UIDB/00511/2020 (LEPABE)/FCT/MCTES (PIDDAC); Germirrad-POCI-01-0247-FEDER-072237, funded by FEDER funds through COMPETE2020

Word Cloud

Created with Highcharts 10.0.0woundresistancebiofilmisolatesbiofilmsMICanimalsmedicinechronicstudymareantisepticoneantibioticsisolateantibioticformconcentration10×removalhumanveterinarywoundsoftenrelatedpolymicrobialinfectionspresencecompromiseseffectivenesstherapeuticapproachesLusitanopresented21-day-oldtreatedswabsamplecollectedthreeisolatedshowpanelHowevershowedprofilecarbapenemsfluoroquinolonesmaysuggestcross-resistancegiventherapyappliedpreviousyearexperimentsconductedassessabilityascertainsusceptibilitygentamicinresultsdemonstratedproducedGentamicinminimuminhibitorycaused593%857%highestpercentageobtainedrevealsequinecolonizedresistantbacteriacolonizersdemonstratingrelevanceadequatediagnosistreatmentsuspicionbiofilm-infectedalsohighlightspossibilitytransmissionhumansenvironmentBiofilmProductionCriticalAntibiotic-ResistantPathogensEquineWoundPseudomonasaeruginosaStaphylococcusaureusantimicrobialhealthzoonoticdisease

Similar Articles

Cited By (2)